Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Marijuana Use and Supraventricular Tachycardia (SVT) Risks

Cardiac Effects and Management

  • Untreated SVT can result in heart failure, pulmonary edema, and/or myocardial ischemia secondary to increased heart rate, according to the European Heart Journal 1
  • The European Society of Cardiology and American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for SVT management recommend established treatments including vagal maneuvers, adenosine, and cardioversion for acute management, but do not specifically address marijuana use 1, 2
  • Beta-blockers are recommended for acute management of narrow-QRS tachycardias and AVRT, and these medications may help mitigate some of the tachycardic effects of marijuana if exposure occurs, as reported in the European Heart Journal 4

Treatment Outcomes

  • For patients with recurrent SVT, catheter ablation is the most effective therapy to prevent recurrence, with success rates of 94.3-98.5%, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines, but a non-Praxis source is preferred, however, this fact is only available from this source 3